Barclays Maintains Thermo Fisher Scientific(TMO.US) With Hold Rating, Maintains Target Price $610
Express News | Thermo Fisher Scientific Inc : RBC Cuts Target Price to $689 From $692
Baird Adjusts Thermo Fisher Scientific Price Target to $632 From $622, Maintains Outperform Rating
Olink Reveal Seamlessly Connects Genomics and Proteomics, Empowering Researchers to Uncover the Dynamic Mechanisms Underlying Biology
Apple, AT&T, Tesla, GM, Microsoft, and More Stocks to Watch This Week
Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass
Earnings Week Ahead: TSLA, META, AAPL, MSFT, INTC, MA, XOM, LUV and More
Earnings Preview: TMO to Report Financial Results Pre-market on January 30
$Thermo Fisher Scientific(TMO.US)$ is scheduled to release its financial results pre-market on January 30 ET. Earnings PreviewAnalysts estimate $Thermo Fisher Scientific(TMO.US)$ to post revenue of
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery
Is Thermo Fisher Stock Worth Holding on to in Your Portfolio?
Life Sciences Stocks Fall on NIH Funding Concerns
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
This Healthcare Stock Might Just Be RFK Jr. Proof -- Barrons.com
Oligonucleotide CDMO Market to Hit US$6.73 Billion by 2029 With 21.8% CAGR | MarketsandMarkets
Thermo Fisher Scientific Unusual Options Activity For January 21
Asia-Pacific Cell and Gene Therapy Manufacturing QC Research Report 2024-2033 With Danaher, F. Hoffmann-La Roche, and Thermo Fisher Scientific Leading the $1.3+ Billion Market - ResearchAndMarkets.com
Serum-free Media Market Trends Analysis Report 2025-2030, With Profiles of Thermo Fisher Scientific, Sartorius, Merck, Lonza, Danaher, Fujifilm, MP Biomedicals, Corning, PAN-Biotech and R&D Systems
$100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today
Single-use Technologies for Biopharmaceuticals Market to 2029 With Sartorius, Danaher, Merck, and Thermo Fisher Scientific Leading the $11.2 Billion Industry - ResearchAndMarkets.com
Goldman Sachs Adjusts Thermo Fisher Scientific Price Target to $630 From $655